Jubilant Life Sciences is currently trading at Rs. 431.20, up by 12.00 points or 2.86% from its previous closing of Rs. 419.20 on the BSE.
The scrip opened at Rs. 426.00 and has touched a high and low of Rs. 436.00 and Rs. 426.00 respectively. So far 44,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 455.00 on 07-Dec-2015 and a 52 week low of Rs. 116.20 on 26-Dec-2014.
Last one week high and low of the scrip stood at Rs. 436.00 and Rs. 416.00 respectively. The current market cap of the company is Rs. 6,880.00 crore.
The promoters holding in the company stood at 54.02% while Institutions and Non-Institutions held 18.12% and 27.85% respectively.
Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) and registered foreign portfolio investors (RFPI) to buy up to 45% stake in Jubilant Life Sciences under the portfolio investment scheme.
The company had earlier received approval from its Board and shareholders for hiking the limit of purchase of its equity shares and convertible debentures by FIIs/RFPIs, who can now buy these instruments through primary and secondary markets.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery Solutions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: